INIT — Initiator Pharma A/S Income Statement
0.000.00%
Last trade - 00:00
- SEK486.94m
- SEK473.10m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | DAS | DAS | DAS | DAS | DAS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.34 | 10.5 | 23.1 | 41.7 | 27 |
Operating Profit | -9.34 | -10.5 | -23.1 | -41.7 | -27 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.97 | -10.2 | -24.2 | -44.1 | -27.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.29 | -8.7 | -21.1 | -38.5 | -22.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.29 | -8.7 | -21.1 | -38.5 | -22.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.29 | -8.7 | -21.1 | -38.5 | -22.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.317 | -0.296 | -0.481 | -0.796 | -0.436 |
Dividends per Share |